Abstract:Background Diagnosis of colorectal cancer (CRC) during early stages can greatly improve patient outcome. Although technical advances in the field of genomics and proteomics have identified a number of candidate biomarkers for non-invasive screening and diagnosis, developing more sensitive and specific methods with improved cost-effectiveness and patient compliance has tremendous potential to help combat the disease. Methods We enrolled three cohorts of 479 subjects, including 226 CRC cases, 197 healthy controls, and 56 advanced precancerous lesions (APC). In the discovery cohort, we used quantitative mass spectrometry to measure the expression profile of plasma proteins and applied machine-learning to select candidate proteins. We then developed a targeted mass spectrometry assay to measure plasma concentrations of seven proteins and a logistic regression classifier to distinguish CRC from healthy subjects. The classifier was further validated using two independent cohorts. Results The seven-protein panel consisted of leucine rich alpha-2-glycoprotein 1 (LRG1), complement C9 (C9), insulin-like growth factor binding protein 2 (IGFBP2), carnosine dipeptidase 1 (CNDP1), inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3), serpin family A member 1 (SERPINA1), and alpha-1-acid glycoprotein 1 (ORM1). The panel classified CRC and healthy subjects with high accuracy, since the area under curve (AUC) of the training and testing cohort reached 0.954 and 0.958. The AUC of the two independent validation cohorts was 0.905 and 0.909. In one validation cohort, the panel had an overall sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 89.9%, 81.8%, 89.2%, and 82.9%, respectively. In another blinded validation cohort, the panel classified CRC from healthy subjects with a sensitivity of 81.5%, specificity of 97.9%, and overall accuracy of 92.0%. Finally, the panel was able to detect APC with a sensitivity of 49%. Conclusions This seven-protein classifier is a clear improvement compared to previously published blood-based protein biomarkers for detecting early-stage CRC, and is of translational potential to develop into a clinically useful assay.

[Classification and Diagnostic Prediction of Colorectal Cancer Using Protein Profiling of Serum and Bioinformatics].

An Integrated Approach to the Detection of Colorectal Cancer Utilizing Proteomics and Bioinformatics

A Serum Proteomic Pattern for the Detection of Colorectal Adenocarcinoma Using Surface Enhanced Laser Desorption and Ionization Mass Spectrometry

Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning

Classification and Diagnostic Prediction of Gastric Cancer Using Protein Profiling of the Serum and Bioinformatics

A Proteomic Classifier Panel for Early Screening of Colorectal Cancer: a Case Control Study

[Use of Laser Capture Microdissection and Surface-Enhanced Laser Desorption Ionization Time-of-flight Mass Spectrometry to Screen Differential Proteins in Lung Adenocarcinoma and Lung Squamous Carcinoma].

Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.

[Establish Predictive Model of Colorectal Cancer by Using Surface Enhanced Laser Desorption/ionization-Time of Flight-Mass Spectrometry].

Diagnosis of pancreatic adenocarcinoma using protein chip technology.

Research on the biomarkers for the prediction of efficacy in first-line chemotherapy of metastatic colorectal cancer using SELDI-TOF-MS

Evaluation of the Diagnostic Value of Serum-Based Proteomics for Colorectal Cancer.

Artificial Neural Networks Analysis Of Surface-Enhanced Laser Desorption/Ionization Mass Spectra Of Serum Protein Pattern Distinguishes Colorectal Cancer From Healthy Population

[Application of Serum Protein Pattern Model in Diagnosis of Colorectal Cancer].

Preoperatively Molecular Staging with CM10 ProteinChip and SELDI-TOF-MS for Colorectal Cancer Patients

Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.

Serum proteomic profiling for the early diagnosis of colorectal cancer.

Proteomic Profiling Reveals a Signature for Optimizing Prognostic Prediction in Colon Cancer

Comprehensive serum proteomics profiles and potential protein biomarkers for the early detection of advanced adenoma and colorectal cancer

An Integrated Approach Utilizing Proteomics and Bioinformatics to Detect Ovarian Cancer

Molecular Staging with CM10 ProteinChip and SELDI-MS-TOF for Colorectal Cancer Patients Before Surgery.